IDEXX Labs Q2 Profit Edges Down, Backs 2015 Outlook - Quick Facts

(RTTNews) - Pet healthcare company IDEXX Laboratories, Inc. (IDXX) reported that second-quarter net income attributable to stockholders edged down to $56.91 million from $57.22 million in the prior-year quarter, while earnings per share grew to $0.60 from last year's $0.55.

Earnings for the latest quarter had a negative $0.05 per share impact related to net changes in foreign exchange rates.

On average, eight analysts polled by Thomson Reuters expected the company to report earnings of $0.57 per share for the quarter. Analysts' estimates typically exclude one-time items.

Revenues for the quarter grew 6 percent to $413.34 million, from $390.12 million in the same quarter last year. Analysts estimated revenues of $413.11 million for the quarter. Normalized organic revenue growth was 11 percent.

Looking ahead to fiscal 2015, the company continues to expect adjusted earnings in the range of $2.07 to $2.12 per share, on projected revenues between $1.60 billion and $1.62 billion. Street is currently looking for full-year 2015 earnings of $2.09 per share on annual revenues of $1.60 billion.